A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells.
To generate a novel oncolytic vaccinia virus with improved safety and productivity, the genome of smallpox vaccine strain LC16m8 was modified by a bacterial artificial chromosome system. By using LC16m8, a replicating virus homologous to the target virus, as a helper virus for the bacterial artifici...
Saved in:
| Main Authors: | Go Okita, Kiyotaka Suenaga, Masashi Sakaguchi, Toshio Murakami |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0312205 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy
by: Chunqing Gao, et al.
Published: (2024-09-01) -
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines
by: Getahun Abate, et al.
Published: (2025-05-01) -
Research progress and development potential of oncolytic vaccinia virus
by: Xinyu Zhang, et al.
Published: (2025-04-01) -
Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy
by: Mingyong Zha, et al.
Published: (2025-05-01) -
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
by: David L Bartlett, et al.
Published: (2020-05-01)